Showing results (81-90 of 355) with videos related to
Sort By:
Pageof 36
Diabetes|July 1, 1997
Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathyF S Nielsen, P Rossing, M A Gall, et al.Diabetes|September 1, 1994
Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathyF S Nielsen, P Rossing, M A Gall, et al.Kidney International. Supplement|January 4, 1998
Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathyH P Hansen, F S Nielsen, P Rossing, et al.Clinical Science (London, England : 1979)|December 1, 1998
Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathyV B Sørensen, P Rossing, L Tarnow, et al.Diabetes|May 4, 2001
Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patientsO Poirier, V Nicaud, N Vionnet, et al.Diabetes Care|May 20, 1998
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patientsF S Nielsen, A Sato, S Ali, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patientsM Lajer, L Tarnow, J Fleckner, et al.Scandinavian Journal of Clinical and Laboratory Investigation|September 25, 2001
Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathyB Myrup, P Rossing, T Jensen, et al.Diabetologia|April 27, 2013
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1M G A van Eupen, M T Schram, H M Colhoun, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathyL Tarnow, C D Stehouwer, J J Emeis, et al.Pageof 36